Tao, Z. et al. Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients. Front Oncol 10, 1023 (2020).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Cooper, L. A. D. et al. PanCancer insights from The Cancer Genome Atlas: the pathologist’s perspective. J Pathol 244, 512–524 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Brittain, H. K., Scott, R. & Thomas, E. The rise of the genome and personalised medicine. Clinical Medicine 17, 545–551 (2017).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zehir, A. et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients. Nat Med 23, 703–713 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Huang, K. L. et al. Pathogenic Germline Variants in 10,389 Adult Cancers. Cell 173, 355–370 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Li, Y. et al. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data. BMC Genomics 18, 508 (2017).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Tomczak, K., CzerwiÅ„ska, P. & Wiznerowicz, M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn) 19, A68–A77 (2015).PubMedÂ
Google ScholarÂ
Cline, M. S. et al. Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser. Sci Rep 3, 2652–2657 (2013).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhou, S. et al. Landscape of RAS Variations in 17,993 Pan-cancer Patients Identified by Next-generation Sequencing. Pathology & Oncology Research 26, 2835–2837 (2020).ArticleÂ
CASÂ
Google ScholarÂ
Korkut, A. et al. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-b Superfamily. Cell Systems 7, 422–437 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Sanchez-Vega, F. et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 173, 321–337 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Weinstein, J. N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet 45, 1113–1120 (2013).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Che, H. et al. Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets. Clinical Chemistry 68, 1164–1176 (2022).ArticleÂ
PubMedÂ
Google ScholarÂ
Zhang, J. et al. 5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer. Genomics Proteomics Bioinformatics 16, 187–199 (2018).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wan, J. C. M. et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nature Reviews Cancer 17, 223–238 (2017).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Diaz, L. A. Jr & Bardelli, A. Liquid Biopsies: Genotyping Circulating Tumor DNA. J Clin Oncol 32, 579–586 (2014).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Burgener, J. M. et al. Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 27, 4230–4244 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Han, X., Wang, J. & Sun, Y. Circulating Tumor DNA as Biomarkers for Cancer Detection. Genomics Proteomics Bioinformatics 15, 59–72 (2017).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yeh, P. et al. Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia. Nat Commun 8, 14756 (2017).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bettegowda, C. et al. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies. Sci Transl Med 6, 224ra224 (2014).ArticleÂ
Google ScholarÂ
Zhang, Y. et al. Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. Nat Commun 12, 11 (2021).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ng, C. K. Y. et al. Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study. Annals of Oncology 29, 1286–1291 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Gremel, G. et al. Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA. Annals of Oncology 27, 1959–1965 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Sacher, A. G. et al. Prospective validation of rapid plasma genotyping as a sensitive and specific tool for guiding lung cancer care. JAMA Oncol 2, 1014–1022 (2016).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Murtaza, M. et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat Commun 6, 8760 (2015).ArticleÂ
ADSÂ
PubMedÂ
Google ScholarÂ
Zheng, H., Zhu, M. S. & Liu, Y. FinaleDB: a browser and database of cell-free DNA fragmentation patterns. Bioinformatics 37, 2502–2503 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Jeong, T.-D. et al. Effects of Pre-analytical Variables on Cell-free DNA Extraction for Liquid Biopsy. Lab Med Online 9, 45–56 (2019).ArticleÂ
Google ScholarÂ
Jiang, T. et al. Heterogeneity of neoantigen landscape between primary lesions and their matched metastases in lung cancer. Transl Lung Cancer Res 9, 246–256 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhou, Y. et al. Whole exome sequencing identifies novel candidate mutations in a Chinese family with left ventricular noncompaction. Molecular Medicine Reports 17, 7325–7330 (2018).CASÂ
PubMedÂ
Google ScholarÂ
Auwera, G. A. et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics 43, 11.10.11–11.10.33 (2013).
Google ScholarÂ
Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Research 38, e164 (2010).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Scott, A. D. et al. CharGer: clinical Characterization of Germline variants. Bioinformatics 35, 865–867 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biology 17 (2016).Jiang, T. et al. Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma. Theranostics 11, 257–267 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Li, C. et al. Genome Variation Map: a worldwide collection of genome variations across multiple species. Nucleic Acids Research 49, D1186–D1191 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Xue, Y. et al. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Research 50, D27–D38 (2022).ArticleÂ
CASÂ
Google ScholarÂ
Biological project library of China. https://ngdc.cncb.ac.cn/bioproject/browse/PRJCA027469 (2024).Chen, T. et al. The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types. Genomics, Proteomics & Bioinformatics 19, 578–583 (2021).ArticleÂ
Google ScholarÂ
Raw sequence database of China. https://ngdc.cncb.ac.cn/gsa-human/browse/HRA004543 (2023).Sondka, Z. et al. COSMIC: a curated database of somatic variants and clinical data for cancer. Nucleic Acids Research 52, D1210–D1217 (2024).ArticleÂ
PubMedÂ
Google ScholarÂ
Pan, Q. et al. VARAdb: a comprehensive variation annotation database for human. Nucleic Acids Research 49, D1431–D1444 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Wang, T. et al. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers. Nucleic Acids Research 49, D1289–D1301 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ